MGAT1
Basic information
Region (hg38): 5:180784780-180815652
Previous symbols: [ "MGAT", "GLYT1" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 81.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
ENST00000307826.5 | ENSP00000311888.4 | 1 | yes | - |
ENST00000333055.8 | ENSP00000332073.3 | 1 | - | - |
ENST00000393340.7 | ENSP00000377010.3 | 1 | - | - |
ENST00000427865.2 | ENSP00000402838.2 | 1 | - | - |
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (71 variants)
- not_provided (8 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MGAT1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002406.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 4 | 4 | 9 | ||
| missense | 69 | 2 | 1 | 72 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 70 | 6 | 5 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MGAT1 | protein_coding | protein_coding | ENST00000446023 | 1 | 25112 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125696 | 0 | 4 | 125700 | 0.0000159 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.51 | 230 | 304 | 0.756 | 0.0000222 | 2823 |
| Missense in Polyphen | 41 | 115.09 | 0.35623 | 1116 | ||
| Synonymous | -1.53 | 164 | 141 | 1.16 | 0.0000106 | 957 |
| Loss of Function | 3.41 | 0 | 13.5 | 0.00 | 6.71e-7 | 127 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000477 | 0.0000462 |
| European (Non-Finnish) | 0.00000881 | 0.00000880 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Initiates complex N-linked carbohydrate formation. Essential for the conversion of high-mannose to hybrid and complex N-glycans.;
- Pathway
- N-Glycan biosynthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;N-glycan trimming and elongation in the cis-Golgi;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;N-Glycan biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- 0.00172
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.3
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.514
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- in utero embryonic development;UDP-N-acetylglucosamine catabolic process;protein glycosylation;protein N-linked glycosylation;protein N-linked glycosylation via asparagine
- Cellular component
- Golgi membrane;Golgi apparatus;membrane;integral component of membrane;extracellular exosome;extracellular vesicle
- Molecular function
- alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity;acetylglucosaminyltransferase activity;manganese ion binding